EMBLEM
Twenty years of EMBLEM
Reflecting on 20 years of EMBLEM…
EMBL spinoff to help antibody discovery
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies…
EMBL spin-off Luxendo acquired by Bruker
Accelerating researchers’ access to next-generation light-sheet microscopy…
New EMBL and GSK collaboration
GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms…
SPIM doctors
From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.…
Lighting the way
A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
The transparent organism
A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…
